Tudor Investment Corp’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
VCM
NTCM
Tudor Investment Corp's IRMD Position: Q1 2026 in Review
Tudor Investment Corp increased its iRadimed (IRMD) stake by 130% in Q1 2026, buying an estimated $4.07M and bringing the position to 71,836 shares worth $6.91M. The position accounts for 0.01% of the portfolio, ranked #965.
Tudor Investment Corp first reported a position in IRMD in Q1 2023 and has held it in 11 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.
- Tudor Investment Corp held 71,836 shares of iRadimed worth $6.91M as of Q1 2026.
- Tudor Investment Corp bought 40,659 iRadimed shares in Q1 2026, an estimated $4.07M.
- iRadimed made up 0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #965 holding.
- Tudor Investment Corp first reported a position in iRadimed in Q1 2023 and has held it in 11 quarters since.
- 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.
Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.